Shares in Danish drugmaker Bavarian Nordic, which manufactures a vaccine targeting mpox, soared Thursday after the World Health Organization (WHO) declared an mpox surge in Africa a global public health emergency. Bavarian Nordic, whose vaccine has been licensed for preventing mpox since 2019, saw its shares rise more than eight percent on the Copenhagen Stock Exchange by midday on Thursday.
Related Articles
Don't miss out on breaking stories and in-depth articles.